carvedilol has been researched along with Thrombotic Microangiopathies in 1 studies
Thrombotic Microangiopathies: Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yin, T | 1 |
| Alquist, CR | 1 |
1 other study available for carvedilol and Thrombotic Microangiopathies
| Article | Year |
|---|---|
Hemolytic Anemia and Thrombocytopenia: How to Treat?
Topics: Amlodipine; Anemia, Hemolytic; Carvedilol; Cocaine; Humans; Hypertension; Male; Medication Adherence | 2020 |